Laparoscopic Versus Open Resection for Rectal Cancer: A Noninferiority Meta-analysis of Quality of Surgical Resection Outcomes

Objective: To determine whether laparoscopic surgery is noninferior to open surgery for rectal cancer in terms of quality of surgical resection outcomes. Background: Randomized clinical trials (RCTs) have evaluated the oncologic safety of laparoscopic versus open surgery for rectal cancer with conflicting results. Prior meta-analyses comparing these operative approaches in terms of quality of surgical resection aimed to demonstrate if one approach was superior. However, this method is not appropriate and potentially misleading when noninferiority RCTs are included. Methods: MEDLINE, EMBASE, and Cochrane were searched to identify RCTs comparing these operative approaches. Risk differences (RDs) were pooled using random-effects meta-analyses. One-sided Z tests were used to determine noninferiority. Noninferiority margins (&Dgr;NI) for circumferential resection margin (CRM), plane of mesorectal excision (PME), distal resection margin (DRM), and a composite outcome (“successful resection”) were based on the consensus of 58 worldwide experts. Results: Fourteen RCTs were included. Laparoscopic resection was noninferior compared with open resection for the rate of positive CRM [RD 0.79%, 90% confidence interval (CI) −0.46 to 2.04, &Dgr;NI = 2.33%, PNI = 0.026], incomplete PME (RD 1.16%, 90% CI −0.27 to 2.59, &Dgr;NI = 2.85%, PNI = 0.025), and positive DRM (RD 0.15%, 90% CI −0.58 to 0.87, &Dgr;NI = 1.28%, PNI = 0.005). For the rate of “successful resection” (RD 6.16%, 90% CI 2.30–10.02), the comparison was inconclusive when using the &Dgr;NI generated by experts (&Dgr;NI = 2.71%, PNI = 0.07), although no consensus was achieved for this &Dgr;NI. Conclusions: Laparoscopy was noninferior to open surgery for rectal cancer in terms of individual quality of surgical resection outcomes. These findings are concordant with RCTs demonstrating noninferiority for long-term oncologic outcomes between the 2 approaches.

[1]  J. Fleshman,et al.  Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial , 2019, Annals of surgery.

[2]  N. Baxter,et al.  Pathologic Outcomes of Laparoscopic vs Open Mesorectal Excision for Rectal Cancer. , 2017, JAMA surgery.

[3]  F. Brunetti,et al.  Pathologic Outcomes of Laparoscopic vs Open Mesorectal Excision for Rectal Cancer: A Systematic Review and Meta-analysis , 2017, JAMA surgery.

[4]  G. Guyatt,et al.  How to Use a Randomized Clinical Trial Addressing a Surgical Procedure: Users' Guide to the Medical Literature. , 2016, JAMA surgery.

[5]  Daniel J Sargent,et al.  Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. , 2015, JAMA.

[6]  V. Gebski,et al.  Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial. , 2015, JAMA.

[7]  Jacob Rosenberg,et al.  A randomized trial of laparoscopic versus open surgery for rectal cancer. , 2015, The New England journal of medicine.

[8]  P. Quirke,et al.  Multicenter randomized controlled trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme: EnROL. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Park,et al.  Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. , 2014, The Lancet. Oncology.

[10]  D. Dietz,et al.  Multidisciplinary Management of Rectal Cancer: the OSTRICH , 2013, Journal of Gastrointestinal Surgery.

[11]  W. Hop,et al.  Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. , 2013, The Lancet. Oncology.

[12]  D. Jayne,et al.  Long‐term follow‐up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer , 2013, The British journal of surgery.

[13]  Xinxiang Li,et al.  Short-term outcomes of laparoscopic total mesorectal excision compared to open surgery. , 2012, World journal of gastroenterology.

[14]  G. Guyatt,et al.  How to use a noninferiority trial: users' guides to the medical literature. , 2012, JAMA.

[15]  M. Viswanathan,et al.  Assessing equivalence and noninferiority. , 2012, Journal of clinical epidemiology.

[16]  H. Lippert,et al.  Factors influencing the quality of total mesorectal excision , 2012, The British journal of surgery.

[17]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[18]  C. Sempoux,et al.  Factors Predicting the Quality of Total Mesorectal Excision for Rectal Cancer , 2010, Annals of surgery.

[19]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[20]  J. Park,et al.  Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. , 2010, The Lancet. Oncology.

[21]  P. Parrilla,et al.  Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer , 2009, The British journal of surgery.

[22]  K. Leung,et al.  Long-Term Morbidity and Oncologic Outcomes of Laparoscopic-Assisted Anterior Resection for Upper Rectal Cancer: Ten-Year Results of a Prospective, Randomized Trial , 2009, Diseases of the colon and rectum.

[23]  J. Monson,et al.  Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial , 2009, The Lancet.

[24]  K. Leung,et al.  Laparoscopic-Assisted Versus Open Abdominoperineal Resection for Low Rectal Cancer: A Prospective Randomized Trial , 2008, Annals of surgical oncology.

[25]  I. Nagtegaal,et al.  What is the role for the circumferential margin in the modern treatment of rectal cancer? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  D. Jayne,et al.  Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. Braga,et al.  Laparoscopic Resection in Rectal Cancer Patients: Outcome and Cost-Benefit Analysis , 2007, Diseases of the colon and rectum.

[28]  M. Tzardi,et al.  Lymph Node Clearance after Total Mesorectal Excision for Rectal Cancer: Laparoscopic versus Open Approach , 2007, Digestive Diseases.

[29]  Philip Quirke,et al.  Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial , 2005, The Lancet.

[30]  W Schwenk,et al.  Short term benefits for laparoscopic colorectal resection. , 2005, The Cochrane database of systematic reviews.

[31]  H. Putter,et al.  Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands , 2002, The British journal of surgery.

[32]  Bjørn Møller,et al.  A National Strategic Change in Treatment Policy for Rectal Cancer—Implementation of Total Mesorectal Excision as Routine Treatment in Norway. A National Audit , 2002, Diseases of the colon and rectum.

[33]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[34]  I. Nagtegaal,et al.  Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  L. Påhlman,et al.  Changing strategy for rectal cancer is associated with improved outcome , 1999, The British journal of surgery.

[36]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[37]  D L Sackett,et al.  An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.

[38]  P. Quirke,et al.  LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION Histopathological Study of Lateral Tumour Spread and Surgical Excision , 1986, The Lancet.

[39]  R. Heald,et al.  RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER , 1986, The Lancet.

[40]  T. Chesney,et al.  Defining Non-inferiority Margins for Quality of Surgical Resection for Rectal Cancer : A Delphi Consensus Study , 2018 .

[41]  K. Leung,et al.  Laparoscopic-assisted versus open total mesorectal excision with anal sphincter preservation for mid and low rectal cancer: a prospective, randomized trial , 2013, Surgical Endoscopy.

[42]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[43]  Karen Shashok,et al.  BMC Medical Research Methodology BioMed Central Debate Conducting a meta-ethnography of qualitative literature: Lessons learnt , 2008 .

[44]  J. Gama-Rodrigues,et al.  Conventional approach x laparoscopic abdominoperineal resection for rectal cancer treatment after neoadjuvant chemoradiation: results of a prospective randomized trial. , 2003, Revista do Hospital das Clinicas.